Startup Magenta Therapeutics licenses technologies from Harvard, MGH, and Boston Children’s that could transform treatment

New startup will leverage a method for simultaneously sequencing and mapping thousands of RNAs within cells and tissues to advance development of diagnostics and discover new drug targets

Harvard scientists identify spark plug that ignites nerve cell damage in Lou Gehrig’s disease

Harvard licenses powerful molecular screening platform to Kyulux, developer of OLED display technologies